EverCross™ AB35W05040080 (UDI 00821684061381)Recalls & reported problems
Ev3, Inc · PTA AB35W05040080 EVERCROSS 035 V05 · Class 2
All models of EverCross (114)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00821684061381), received between Jul 27, 2017 and Nov 21, 2018 — classified as 1 death, 1 injury.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
1 other recall cover devices cleared under the same FDA submission (K103322); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Burst Container or Vessel1
- Difficult to Remove1
Patient problems
- Death1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 21, 2018Burst Container or Vessel; Burst Container or Vessel
PHYSICIAN USED AN EVERCROSS BALLOON DURING TREATMENT OF THE PATIENT¿S LEFT SUBCLAVIAN VEIN. IFU WAS FOLLOWED AND THE DEVICE WAS PREPPED WITHOUT ISSUE. NON-MEDTRONIC WIRES 5FR 10 CM SHEATH AND INFLATION DEVICE WERE USED. IT IS REPORTED THAT THE BALLOON RUPTURED FOLLOWING FIRST INFLATION. THE BALLOON WAS INFLATED TO RATED BURST PRESSURE (RBP). WHEN THE BURST OCCURRED, THE BALLOON BROKE OFF THE CATHETER AND WAS UNABLE TO BE REMOVED FROM THE PATIENT. EXCESSIVE FORCE WAS USED WHEN TRYING TO WITHDRAW THE BALLOON. IT IS BELIEVED THAT THE BALLOON REMAINED ATTACHED TO THE CATHETER FOLLOWING THE BURST UNTIL IT REACHED A MORE PROXIMAL STENOSIS IN WHICH EXCESSIVE FORCE WAS USED IN ATTEMPT TO CROSS THIS LESION. IT APPEARS THAT THIS PROXIMAL LESION IS WHERE THE BALLOON CAME APART FROM THE CATHETER. PATIENT WAS TAKEN TO SURGERY TO REMOVE THE BALLOON. NO ATTEMPTS AT SNARING THE BALLOON WERE MADE.
Patient problems: Patient Problem/Medical Problem
MAUDE report 8096072 ↗DeathJul 27, 2017Difficult to Remove; Difficult to Remove
PHYSICIAN USED AN EVERCROSS PTA BALLOON WITH A 6 F SHEATH AND.035 GUIDEWIRE FOR THE TREATMENT OF A MODERATELY TORTUOUS, SEVERELY CALCIFIED 40MM LESION IN THE RIGHT PROXIMAL SUPERFICIAL FEMORAL ARTERY OF DIAMETER 6MM WHICH EXHIBITED CTO (CHRONIC TOTAL OCCLUSION). EMBOLIC PROTECTION WAS NOT USED. THE DEVICE IFU WAS FOLLOWED AND NO ISSUES NOTED DURING PREP. THE BALLOON WAS INFLATED USING AN INFLATION DEVICE (INFLATION FLUID UNKNOWN) TO A PRESSURE OF 10ATMS. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED SENT. THERE WAS RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS USED DURING DELIVERY. IT WAS REPORTED THAT AFTER INFLATION, THE BALLOON BECAME STUCK IN THE PATIENT¿S LEG. WHEN PHYSICIAN TRIED TO RETRIEVE IT, THE PATIENT DEVELOPED A LEAK AT THE BASE OF HER AORTA (BALLOON WAS FULLY DEFLATED FOR REMOVAL). PATIENT WAS TRANSFERRED TO THE OPERATING ROOM FOR FEMORAL ENDARTERECTOMY FOLLOWING SEVERAL ATTEMPTS AT REMOVING THE BALLOON. THE PATIENT DIED DAYS LATER AFTER THE PROCEDURE IN THE ICU. PHYSICIAN REPORTED THE CAUSE OF DEATH IS SEVERE PERIPHERAL VASCULAR DISEASE (PVD).
Patient problems: Death
MAUDE report 6749437 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K103322. One submission often covers many models, so check the product and lot details in each record.
- Z-1489-2014 · Apr 9, 2014 · Terminatedev3 EverCross 0.035" OTW PTA Dilatation Catheter, 6mm x 120mm x 135cm, REF: AB35W06120135. and ev3 EverCross 0.035" OTW PTA Dilatation Catheter, 6mm x 40mm x, 80cm REF: AB35W
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page